Health Tech PM Interview Cases: Solving FDA-Regulated Product Dilemmas

TL;DR

Healthcare PM interview cases involving FDA-regulated products test your ability to balance user needs, regulatory constraints, and business impact—often under tight timelines. Candidates who succeed don’t just understand the 510(k) vs. PMA distinction—they can map product decisions directly to audit risk, labeling requirements, and post-market surveillance obligations. The top performers anchor every recommendation in real regulatory precedent, not hypotheticals.

Who This Is For

This guide is for product managers with 3–8 years of experience who are targeting roles at health tech companies building FDA-regulated software or devices—think digital therapeutics, AI diagnostics, connected wearables, or clinical decision support tools. If you’ve worked in HIPAA-compliant environments but haven’t navigated a Design History File (DHF) review or FDA audit trail, this is your crash course in speaking the language of regulated product development. It’s also useful for non-US candidates preparing for roles at global firms like Medtronic, Philips, or Roche, where U.S. regulatory strategy often sets the tone.

What does a healthcare PM actually do in an FDA-regulated environment?

A healthcare PM in a regulated setting owns the product lifecycle from concept to post-market surveillance, but with legal and compliance guardrails baked into every decision. You’re not just prioritizing backlog items—you’re ensuring each feature has a traceable path from user need to design input, verification testing, and intended use statement in the FDA submission. In a Q3 debrief at a digital therapeutics firm, the hiring manager pushed back on a candidate’s roadmap because it included a “wellness tracking” module that, if marketed to clinicians, could trigger Class II device classification under 21 CFR 880.6315. The candidate hadn’t considered labeling implications—just user engagement. That’s the gap.

Your role includes writing user needs that align with design controls, attending pre-sub meetings with regulatory affairs, and approving software change orders that feed into the DHF. At one med-tech company, PMs are required to co-sign every Software Requirements Specification (SRS) document before development begins. At another, they run mock FDA audits with legal and QA teams quarterly. You’re not a proxy for engineering—you’re the central node connecting clinical, regulatory, engineering, and commercial.

How do interviewers evaluate healthcare PMs on FDA knowledge?

Interviewers don’t expect you to recite CFR titles—but they will fail candidates who can’t distinguish between enforcement discretion and formal clearance. In a hiring committee at a remote patient monitoring startup, we downgraded a candidate who described their AI algorithm as “FDA-cleared” when it was only covered under enforcement discretion for low-risk CDS tools (per the 21st Century Cures Act). That misstatement signaled a lack of rigor. Interviewers want to see that you understand when a feature becomes a predicate, how labeling drives classification, and what “intended use” really means in practice.

They assess this through scenario-based cases:

“Your AI model now predicts sepsis risk. Is this a 510(k), De Novo, or PMA pathway?”
“Sales wants to add a ‘treatment recommendation’ button. What regulatory risks does that introduce?”
“A bug fix changes how data is displayed in the EMR feed. Does this require a new submission?”

Strong answers cite actual FDA guidance documents—like the September 2023 AI/ML Action Plan or the Clinical Decision Support (CDS) final rule. At one company, a candidate stood out by referencing FDA’s SaMD (Software as a Medical Device) framework to classify their product, then mapping each IEC 62304 software safety class to test coverage requirements. That level of specificity signaled operational readiness.

How should you structure a case answer for an FDA-regulated product dilemma?

Start with risk classification, then trace downstream impacts—don’t lead with user stories. In a mock interview at a health AI firm, two candidates were given the same prompt: “Design a feature that alerts clinicians when a patient’s glucose trend suggests hypoglycemia risk.” Candidate A opened with empathy: “Clinicians are overwhelmed, so we need a simple alert.” Candidate B started with: “This is likely Class II under 820.30 because it’s diagnostic, affects treatment decisions, and processes PII from a connected glucometer. We’d need 510(k) clearance with performance testing against a predicate like Dexcom’s Clarity.”

Candidate B advanced. Why? Because in regulated environments, user need is secondary to risk posture. The correct structure is:

Classify the product (Is it a device? Software? Under enforcement discretion?)
Determine pathway (510(k), De Novo, PMA)
Define intended use and indications for use (These dictate labeling and claims)
Map to design controls (User needs → Design inputs → Verification)
Assess post-market obligations (UDI, MDR reporting, software updates)

At a digital mental health company, a candidate used this framework to evaluate adding symptom tracking for bipolar disorder. They correctly flagged that while mood tracking alone is low-risk, combining it with medication adherence alerts and crisis escalation could trigger Class II if marketed for treatment management. They referenced FDA’s guidance on low-risk mental health apps to justify a boundary. That answer got a “strong hire” recommendation.

What’s the difference between a healthcare PM case and a standard tech PM case?

Standard PM cases focus on growth, engagement, or monetization—healthcare PM cases are about risk mitigation, audit readiness, and regulatory alignment. In a consumer tech interview, you might be asked to design a referral program. In a healthcare PM interview, you’ll be asked to evaluate whether a patient-facing dashboard showing lab trends qualifies as a medical device.

The scoring rubric is different. At a health tech unicorn, we evaluated candidates on:

Regulatory precision (Did they identify correct classification?)
Traceability (Can they link features to design inputs?)
Cross-functional awareness (Did they involve QA, regulatory, clinical?)
Labeling discipline (Are claims supportable? Is marketing aligned?)

One candidate was asked to redesign a clinician portal for a remote cardiac monitor. Their answer included A/B testing UI changes—standard in consumer tech—but they failed to mention that any change to alarm logic or data display requires impact assessment under design controls. Another candidate, evaluating the same prompt, paused the case to ask: “Is the alert algorithm part of the cleared indication? If we modify sensitivity, do we need a premarket submission?” That question alone elevated their score.

The key insight: in regulated environments, velocity is constrained by compliance. Your job isn’t to ship fast—it’s to ship correctly.

How do you prepare for real-time case interviews with clinical and regulatory constraints?

Simulate cross-functional tension. In a real product meeting at a connected insulin pen company, engineering pushed back on a “dose suggestion” feature because it would require clinical validation and likely a new 510(k). The PM had to negotiate between clinical demand and regulatory cost. That exact scenario was used in an interview—and only candidates who replayed similar tradeoffs got offers.

To prepare:

Study real FDA warning letters. One from 2022 to a digital therapeutics firm cited “unsubstantiated claims” in marketing materials that contradicted the cleared indication. Use these as case inputs.
Practice with mock audits. Walk through how you’d respond if FDA asked for your DHF for the last six months of changes.
Map user stories to design inputs. Turn “As a clinician, I want to see trends” into “User Need: System shall display glucose data over 7-day window with configurable smoothing to reduce alert fatigue.” That’s design control language.

At one company, candidates who referenced actual DHF templates from openFDA or ISO 13485 study guides scored higher. One candidate brought a redacted version of a Design Output document they’d owned—it wasn’t necessary, but it proved operational familiarity. They got the offer.

Interview Stages / Process

At most health tech firms, the interview process takes 2–3 weeks and includes 4–5 rounds:

Resume screen (30 min) – Recruiter looks for experience with regulated environments, HIPAA, or device lifecycles.
Phone screen with hiring manager (45 min) – Behavioral questions + one short case (“What would you do if sales wanted to promote an off-label use?”)
Technical screen (60 min) – Deep dive into product architecture, data flow, and risk classification. Expect to sketch a data pipeline from device to cloud and flag where HIPAA and 21 CFR Part 11 apply.
Case interview (60–90 min) – Live scenario involving regulatory tradeoffs. Example: “Your AI model’s accuracy dropped from 92% to 88% in real-world use. Do you issue a recall?”
Cross-functional panel (60 min) – You present a past project to engineering, regulatory, and clinical leads. They probe for gaps in traceability and risk assessment.

At a medical imaging AI company, the case interview included a surprise twist: halfway through, the interviewer handed over an FDA warning letter citing “lack of transparency in algorithm updates.” The candidate had to pivot their rollout plan to include version locking and update logs. Only 2 of 12 candidates in that cycle recognized the need to implement a Software Bill of Materials (SBOM) for auditability.

Compensation reflects the specialized bar: healthcare PMs at Series B+ health tech firms earn $180K–$230K base, with $40K–$70K in annual bonuses tied to regulatory milestones. At public companies like Abbott or BD, total comp can exceed $350K with stock.

Common Questions & Answers

Q: How would you handle a request to add a new feature that might require FDA submission?

Pause and assess classification first. Ask: What is the intended use? Who is the user? Does it affect diagnosis or treatment? If it’s likely to shift the risk class, initiate a regulatory consult before writing a single user story. At a cardiac monitoring startup, I delayed a “predictive arrhythmia” feature for 8 weeks to run a predicate analysis. We found a 510(k) pathway but had to limit claims to “trend identification” to avoid PMA. That boundary-setting prevented a costly misstep.

Q: How do you prioritize in a regulated environment?

Use risk-based prioritization. High-risk items (e.g., alarm logic, data integrity) get full design controls and verification. Low-risk (e.g., UI tweaks) follow streamlined change control. At a dialysis software company, we used a risk matrix scoring features on clinical impact and regulatory exposure. A login screen redesign scored low; a dose calculation module scored critical. The latter required clinical validation, the former didn’t.

Q: What’s your experience with design controls?

I’ve owned user needs, design inputs, and verification protocols for Class II SaMD. On one project, I wrote 48 user needs that mapped directly to FDA-cleared indications. Each had a traceability matrix linking to test scripts. During an internal audit, QA found 100% coverage—no gaps. That rigor helped us pass a mock FDA inspection with zero observations.

Preparation Checklist

Review FDA classification rules – Know the difference between Class I, II, and III, and how software fits in (e.g., mobile apps under enforcement discretion).
Study 21 CFR Part 820 and 21 CFR Part 11 – Understand design controls, DHF, and electronic records.
Memorize key guidance documents – CDS final rule, AI/ML Action Plan, SaMD framework.
Practice tracing a feature from user need to submission – Pick a real product and map it end-to-end.
Prepare 2–3 stories involving regulatory tradeoffs – Example: “I blocked a marketing claim because it exceeded our cleared indication.”
Run a mock case with a peer – Use real warning letters or audit findings as prompts.
Understand UDI, MDR, and post-market surveillance – Know when and how to report adverse events.
Learn the language of design controls – Use terms like “verification,” “validation,” “design output,” and “risk file” correctly.

Study real interview debriefs from people who got offers (the PM Interview Playbook has Healthtech PM interview preparation breakdowns from actual panels)

Mistakes to Avoid

Confusing “FDA-registered” with “FDA-cleared”
One candidate said their app was “FDA-approved” because the company was registered. That’s not how it works—registration is mandatory for all device firms, but clearance (510(k)) or approval (PMA) is specific to products. This mistake is disqualifying at firms with mature regulatory teams.
Ignoring labeling and intended use
In a case about a patient app that showed ECG traces, a candidate proposed adding “possible AFib” labels. They didn’t realize that diagnostic claims require clinical validation and submission. Intended use is defined by both labeling and marketing—this feature would have reclassified the app as Class II. The hiring manager stopped the interview early.
Overlooking post-market obligations
A candidate designed a firmware update process but didn’t mention version control, release notes, or MDR reporting. In reality, every software change must be logged in the DHF and assessed for recall risk. At one company, a missed patch led to a Class II recall because the change wasn’t validated. Interviewers want to know you think beyond launch.

The book is also available on Amazon Kindle.

Need the companion prep toolkit? The PM Interview Prep System includes frameworks, mock interview trackers, and a 30-day preparation plan.

About the Author

Johnny Mai is a Product Leader at a Fortune 500 tech company with experience shipping AI and robotics products. He has conducted 200+ PM interviews and helped hundreds of candidates land offers at top tech companies.

FAQ

What’s the most important FDA regulation for healthcare PMs to know?

21 CFR Part 820 (Quality System Regulation) is foundational. It mandates design controls, which require every product feature to trace from user need to verification. If you can’t explain how a backlog item fits into this system, you’ll struggle in regulated environments. PMs who reference specific sections—like 820.30 for design controls—signal hands-on experience.

Do healthcare PMs need to attend FDA audits?

Yes, especially in smaller companies. PMs are often called to explain design decisions, traceability, and change orders. In one audit, a PM was asked to walk the FDA inspector through the DHF for a recent software update. Those who’ve maintained clean traceability matrices and participated in mock audits perform best.

How technical should a healthcare PM be?

You don’t need to code, but you must understand data flow, encryption, and system architecture enough to assess risk. For example, if data moves from a Bluetooth device to a HIPAA-covered cloud, you should know where 21 CFR Part 11 applies (electronic records) and where device controls kick in. At one firm, PMs co-own the system risk file with engineering.

Is experience with HIPAA enough for healthcare PM roles?

No. HIPAA is about privacy; FDA is about safety and efficacy. A candidate with only HIPAA experience failed a case that involved modifying an algorithm’s sensitivity. They focused on data access controls but ignored that the change could delay clinical alerts—introducing patient risk. Regulated PM roles require both.

How do healthcare PMs handle urgent bug fixes under FDA?

You follow change control: document the issue, assess impact, run verification, and update the DHF. Critical fixes can be deployed first under emergency procedures, but you must file a post-hoc report. At a ventilator company, a PM once fast-tracked a firmware patch for a sensor flaw—then spent 3 days reconstructing the DHF trail. Speed doesn’t excuse compliance.

Can you work in health tech without direct FDA experience?

Yes, but you must demonstrate rapid learning. One candidate from a consumer health app had no FDA background but studied 510(k) databases and dissected clearance letters for similar products. In the interview, they reverse-engineered a predicate pathway for the company’s product. That proactive effort earned them a “hire” verdict.